NCT01925482View on ClinicalTrials.gov

Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 13, 2014

Primary Completion Date

April 24, 2015

Study Completion Date

May 19, 2015

Conditions
Middle Ear Gas Exchange
Interventions
DRUG

6%CO2, 25%O2, balance N2

exposure of middle ear to gas

DRUG

6% CO2, 0%O2, balance N2

exposure of middle ear to gas

DRUG

20%CO2, 6%O2, balance N2

exposure of middle ear to gas

DRUG

0%CO2, 6%O2, balance N2

exposure of middle ear to gas

DRUG

6% CO2, 6%O2, balance N2

exposure of middle ear to gas

DRUG

6%CO2, 6%O2, 0%N2, balance argon

exposure of middle ear to gas

Trial Locations (1)

15213

Middle Ear Physiology Laboratory, University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Cuneyt M. Alper

OTHER

NCT01925482 - Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1 | Biotech Hunter | Biotech Hunter